PGL 0.00% 85.0¢ prospa group limited.

nexavar approved for liver cancer

  1. 160 Posts.
    Well, PI-88 is now dead. Nexavar has officially become the drug of choice for liver cancer. Paying more than cash value for PGL shares is now akin to giving away money. Nexavar completed its Phase III trial in less time than it took to plan a Phase III for PI-88 ... lol.
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.